Via the NY Times Dealbook Sanofi-Aventis (NYSE: ADR) may be raising its bid for Genzyme (GENZ) $7 per share. This would result in a roughly $1.8 billion offer increase (outstanding shares x price).
Sanofi Upping its Bid for Genzyme?
Previous post: Dropping Knowledge: What Exactly is Stock?
Next post: Is Apple and/or Steve Jobs Committing Securities Fraud?
{ 0 comments… add one now }